Pylarify Injection
Product Images NDC 71258-022

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pylarify (NDC 71258-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Progenics Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pylarify 01)

Chemical structure diagram of PifluFolastat F-18, the active ingredient in PYILARIFY injection. The structure includes a fluorine-18 isotope label on a pyridine ring, along with amide and carboxylic acid functional groups characteristic of this radiolabeled compound.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

PYLARIFY (piflufolastat F-18) injection label showing multiple-dose vial information. The label indicates the product is sterile, non-pyrogenic, for intravenous use only, with a radioactive concentration range from 37 MBq/mL to 2,960 MBq/mL (1 mCi/mL to 80 mCi/mL) at end of synthesis. It includes batch details, expiration, activity, concentration, and volume fields. Manufactured by Progenics Pharmaceuticals, Inc., NDC 71258-022-01, the label cautions radioactive material and provides storage instructions at controlled room temperature (20°C to 25°C). The 18F half-life is noted as 109.8 minutes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.